Lipocine Inc. financial data

Symbol
LPCN on Nasdaq
Industry
Pharmaceutical Preparations
Location
675 Arapeen Drive, Suite 202, Salt Lake City, United States
State of incorporation
DE
Fiscal year end
December 31
Former names
MARATHON BAR CORP (to 7/9/2013)
Latest financial report
10-K - Q4 2024 - Mar 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.42K % +16.6%
Debt-to-equity 7.51 % -12.7%
Return On Equity 0.04 %
Return On Assets 0.04 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.35M shares +0.65%
Common Stock, Shares, Outstanding 5.35M shares +0.6%
Entity Public Float 42.8M USD +67.2%
Common Stock, Value, Issued 8.86K USD +0.03%
Weighted Average Number of Shares Outstanding, Basic 5.34M shares +1.32%
Weighted Average Number of Shares Outstanding, Diluted 5.42M shares +2.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 89.6K USD
Revenue from Contract with Customer, Excluding Assessed Tax 55K USD
Research and Development Expense 7.35M USD -27.7%
General and Administrative Expense 5M USD +1.97%
Operating Income (Loss) -1.16M USD +93.6%
Nonoperating Income (Expense) 1.16M USD -26.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9.03K USD
Income Tax Expense (Benefit) 481 USD
Net Income (Loss) Attributable to Parent 8.35K USD
Earnings Per Share, Basic -0.74 USD/shares +80.2%
Earnings Per Share, Diluted -0.77 USD/shares +79.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.21M USD +30.1%
Assets, Current 22.3M USD -2.36%
Property, Plant and Equipment, Net 165K USD +42.2%
Other Assets, Noncurrent 23.8K USD 0%
Assets 22.5M USD -2.13%
Accounts Payable, Current 272K USD -80.5%
Accrued Liabilities, Current 921K USD -24.4%
Liabilities, Current 1.51M USD -42.5%
Liabilities 1.51M USD -42.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 9.14K USD +25.9%
Retained Earnings (Accumulated Deficit) -200M USD +0%
Stockholders' Equity Attributable to Parent 21M USD +3.08%
Liabilities and Equity 22.5M USD -2.13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2.41M USD
Net Cash Provided by (Used in) Investing Activities -4.09M USD -174%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 5.35M shares +0.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.69M USD -204%
Deferred Tax Assets, Valuation Allowance 48.2M USD +0.98%
Deferred Tax Assets, Gross 48.2M USD +0.98%
Payments to Acquire Property, Plant, and Equipment 4K USD -85.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 10.2K USD
Lessee, Operating Lease, Liability, to be Paid 439K USD +2.57%
Property, Plant and Equipment, Gross 1.39M USD +6.94%
Lessee, Operating Lease, Liability, to be Paid, Year Two 62.9K USD +2.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 376K USD +2.58%
Preferred Stock, Shares Issued 88.5K shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 221M USD +0.28%
Preferred Stock, Shares Outstanding 88.5K shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%